Central Drug Agency Seeks Clarification From Glenmark On Its COVID Drug

The Drugs Controller General of India (DCGI) has asked for a clarification from Glenmark Pharmaceuticals regarding its alleged "false claims" on the utilisation of anti-viral FabiFlu (favipiravir) on...

from NDTV News - Special https://ift.tt/3jjsiDu

Comments

Popular posts from this blog

Pak's ISI Fuelling Unrest In Bangladesh, Claims Sheikh Hasina's Son

OnePlus 13s Price in India Leaked Ahead of Launch on June 5

Met Gala 2025: BLACKPINK's Jennie, Rose And Lisa Shine In Style